OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge to the biopharmaceutical industry. Multiple strategies can be employed enhance antibody titer, comprising process parameter optimization, cell line development, and the use of perfusion processes. Fine-tuning culture conditions